190 related articles for article (PubMed ID: 24992082)
21. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics of lithium response in bipolar disorder.
Alda M
J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
[TBL] [Abstract][Full Text] [Related]
23. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.
Pan JQ; Lewis MC; Ketterman JK; Clore EL; Riley M; Richards KR; Berry-Scott E; Liu X; Wagner FF; Holson EB; Neve RL; Biechele TL; Moon RT; Scolnick EM; Petryshen TL; Haggarty SJ
Neuropsychopharmacology; 2011 Jun; 36(7):1397-411. PubMed ID: 21389981
[TBL] [Abstract][Full Text] [Related]
24. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
Lee KY; Ahn YM; Joo EJ; Jeong SH; Chang JS; Kim SC; Kim YS
Neurosci Lett; 2006 Mar; 395(2):175-8. PubMed ID: 16289845
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder.
Rybakowski JK; Dmitrzak-Weglarz M; Suwalska A; Leszczynska-Rodziewicz A; Hauser J
Pharmacopsychiatry; 2009 Jan; 42(1):20-2. PubMed ID: 19153942
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between GSK-3 beta -50T/C and DBI +529A/T polymorphisms in Japanese alcoholics].
Kurihara K; Aoki J; Numajiri M; Ikeda K; Kawai A; Waga C; Yoshihara E; Murayama O; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Oct; 45(5):430-6. PubMed ID: 21226341
[TBL] [Abstract][Full Text] [Related]
28. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
[TBL] [Abstract][Full Text] [Related]
29. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
[TBL] [Abstract][Full Text] [Related]
30. Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.
McCarthy MJ; Nievergelt CM; Shekhtman T; Kripke DF; Welsh DK; Kelsoe JR
Genes Brain Behav; 2011 Nov; 10(8):852-61. PubMed ID: 21781277
[TBL] [Abstract][Full Text] [Related]
31. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
32. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
33. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
[TBL] [Abstract][Full Text] [Related]
34. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
Benedetti F; Serretti A; Colombo C; Lorenzi C; Tubazio V; Smeraldi E
Neurosci Lett; 2004 Sep; 368(2):123-6. PubMed ID: 15351432
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
Azab AN; Vainer E; Agam G; Bersudsky Y
J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
[TBL] [Abstract][Full Text] [Related]
36. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T; Yamada K; Ohba H; Iwayama Y; Toyota T; Hattori E; Inada T; Kunugi H; Tatsumi M; Ozaki N; Iwata N; Sakamoto K; Iijima Y; Iwata Y; Tsuchiya KJ; Sugihara G; Nanko S; Osumi N; Detera-Wadleigh SD; Kato T; Yoshikawa T
Neuropsychopharmacology; 2007 Aug; 32(8):1727-37. PubMed ID: 17251911
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
[TBL] [Abstract][Full Text] [Related]
38. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
[TBL] [Abstract][Full Text] [Related]
39. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
Alda M
Mol Psychiatry; 2015 Jun; 20(6):661-70. PubMed ID: 25687772
[TBL] [Abstract][Full Text] [Related]
40. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J
Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
